Evidence map›Paper›PMID 36369329›Full record

ArticleCommunications biology2022

Voltage imaging reveals the dynamic electrical signatures of human breast cancer cells.

Peter Quicke, Yilin Sun, Mar Arias-Garcia, Melina Beykou, Corey D Acker, Mustafa B A Djamgoz, Chris Bakal, Amanda J Foust

Abstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Cancer: A bioelectric disease?Clinical and translational medicine · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Peter Quicke *Department of Bioengineering, Imperial College London, London, SW7 2AL, UK.
Yilin Sun *Department of Bioengineering, Imperial College London, London, SW7 2AL, UK.
Mar Arias-GarciaInstitute of Cancer Research, Cancer Biology, London, SW3 6JB, UK.ORCID 0000-0003-0130-1107
Melina BeykouInstitute of Cancer Research, Cancer Biology, London, SW3 6JB, UK.
Corey D AckerUniversity of Connecticut School of Medicine, R. D. Berlin Center for Cell Analysis and Modeling, Farmington, CT, USA.
Mustafa B A DjamgozDepartment of Life Sciences, Imperial College London, London, SW7 2AZ, UK.
Chris BakalInstitute of Cancer Research, Cancer Biology, London, SW3 6JB, UK. chris.bakal@icr.ac.uk.ORCID 0000-0002-0413-6744
Amanda J FoustDepartment of Bioengineering, Imperial College London, London, SW7 2AL, UK. a.foust@imperial.ac.uk.ORCID 0000-0002-4895-0502

Funding

Biotechnology and Biological Sciences Research Council BB/R009007/1Cancer Research UK C37275/1A20146Wellcome TrustWellcome Trust 201964/Z/16/Z
6 · The paper itself

Abstract

Cancer cells feature a resting membrane potential (V

Indexed as

Epithelial-Mesenchymal TransitionTriple Negative Breast NeoplasmsCell Line, TumorHumansMCF-7 CellsMembrane Potentials

Identifiers

PMID36369329
PMCPMC9652252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.